Aleksandr Leonidovich Kalinkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aleksandr Leonidovich Kalinkin has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr Sergeevich Sorokin
Plekhanov Russian University of Economics
2 shared publications - Elena Anatolyevna Katunina
Federal Center for Brain and Neurotechnologies of the Federal Medical-Biological Agency of Russia
2 shared publications - Elena М. Seredenina
Lomonosov Moscow State University
2 shared publications - Michael V. Ugrumov
Laboratory of Neural and Neuroendocrine Regulations, Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow 119334, Russia
2 shared publications - Valerian Grigoryevich Kucheryanu
Research Institute of General Pathology and Pathophysiology, Moscow, Russia
2 shared publications - Victor Blokhin
Laboratory of Neural and Neuroendocrine Regulations, Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
2 shared publications
Latest Publications
- 21 September 2026
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 16 (2) , 81-85
On the 100th anniversary of the discovery by Russian scientists of periodic phenomena and the phase activity of eye movements during sleep
For many decades, E. Aserinsky and N. Kleitman were considered to be the discoverers of the REM phase of sleep (the “rapid eye movements” sleep phase), who published the results of their research in 1953. However, 70 years later, this fact was questioned, as it was discovered an article published in 1926, in which Russian scientists M.P. Denisova and N.L. Figurin for the first time in the world, not only very detailed descriptions of observations were presented, but also the results of recording respiratory rate, eye and eyelid movements, and general motor activity in the form of a graph (kimogram) in infants of different ages. The authors noted the age-related dynamics of the processes occurring during sleep, dividing them into three periods: first – from birth to 1–2 months, second – from 1–2 months to 2 years, and third – from 2 years. The authors considered the second period, “with its wave-like pattern of sleep”, to be the most interesting “in terms of analysis”, as it most vividly reflected the dynamics of physiological processes during sleep. The discovery by Denisova and Figurin in 1926 of periodic processes during sleep, including the phase activity of eye movements with a period of about 50 minutes, respiration and general motor activity leaves no doubt about the priority of Russian scientists in detecting the “rapid eye movements” sleep phase (REM sleep) and crowns all the main stages of the development of Russian sleep research on at the global level, from the first scientific work in the world history in the field of sleep research, published by Prof. M.M. Manaseina in 1892 up to I.N. Pigarev’s visceral theory of sleep.
- 21 September 2026
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 16 (2) , 81-85
On the 100th anniversary of the discovery by Russian scientists of periodic phenomena and the phase activity of eye movements during sleep
For many decades, E. Aserinsky and N. Kleitman were considered to be the discoverers of the REM phase of sleep (the “rapid eye movements” sleep phase), who published the results of their research in 1953. However, 70 years later, this fact was questioned, as it was discovered an article published in 1926, in which Russian scientists M.P. Denisova and N.L. Figurin for the first time in the world, not only very detailed descriptions of observations were presented, but also the results of recording respiratory rate, eye and eyelid movements, and general motor activity in the form of a graph (kimogram) in infants of different ages. The authors noted the age-related dynamics of the processes occurring during sleep, dividing them into three periods: first – from birth to 1–2 months, second – from 1–2 months to 2 years, and third – from 2 years. The authors considered the second period, “with its wave-like pattern of sleep”, to be the most interesting “in terms of analysis”, as it most vividly reflected the dynamics of physiological processes during sleep. The discovery by Denisova and Figurin in 1926 of periodic processes during sleep, including the phase activity of eye movements with a period of about 50 minutes, respiration and general motor activity leaves no doubt about the priority of Russian scientists in detecting the “rapid eye movements” sleep phase (REM sleep) and crowns all the main stages of the development of Russian sleep research on at the global level, from the first scientific work in the world history in the field of sleep research, published by Prof. M.M. Manaseina in 1892 up to I.N. Pigarev’s visceral theory of sleep.
- 10 April 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 4
Hyperferritinemia in Multiorgan Disease. Diagnostic Criteria and Treatment Strategy Using Standardized Placental Extracts in Metabolic Fatty Liver Disease
Ferritin is an iron metabolism protein involved in the storage and protection of iron ions from uncontrolled oxidation. Serum ferritin levels are used as a biomarker to assess iron homeostasis. However, iron storage is not ferritin’s only biological function. Ferritin is an important biomarker of acute and chronic inflammation, and ferritin levels above 500-1000 ng/mL can indicate inflammatory processes of various origins. Therefore, in patients with existing inflammation, interpreting serum ferritin levels becomes more complex. Hyperferritinemia (ferritin levels of 500 ng/mL and above) accompanies not only iron overload but also liver disease, insulin resistance, cardiovascular and cerebrovascular pathology, COVID-19 (characterized by multiple organ dysfunction), and certain hematological disorders (macrophage activation syndrome, hemophagocytic lymphohistiocytosis) and corresponds to a more severe course of these pathologies. The results of an analysis of 34,266 publications on ferritin, conducted using mathematical methods of topological data analysis, suggest that ferritin (which is also a marker of acute and chronic inflammation) should only be used in combination with other biomarkers (transferrin, hemoglobin, hepcidin, etc.) to assess iron homeostasis. Diagnostic criteria that include serum ferritin levels should take into account the patient’s comorbidity. Depending on the pathology, ferritin levels can vary by four orders of magnitude: from 10-20 ng/ml for iron deficiency anemia to 900,000 ng/ml in individual cases of hemophagocytic lymphohistiocytosis. Ferritin thresholds in the range of 1000-6000 ng/ml are typical for iron overload diseases, macrophage activation syndrome, hemophagocytic lymphohistiocytosis, and coagulation disorders; ferritin thresholds in the range of 500-1000 ng/ml are typical for leukemia, blood transfusions, COVID-19, and other viral infections. At the same time, for bacterial infections, liver and kidney diseases, diabetes mellitus, vascular and neurodegenerative pathologies, threshold values of ferritin in the range of 300-500 ng/ml are of diagnostic interest, which approximately correspond to the established reference intervals for ferritin for adults. Therapeutic strategies for liver disease and other pathologies should consider hyperferritinemia as an indicator of a more severe course of the disease, including due to cytolysis of various tissues in multiorgan pathology. There are no established drugs for the treatment of diseases complicated by hyperferritinemia. Basic and clinical research shows that drugs based on standardized human placental hydrolysates (HPH) can be effectively used in multiorgan pathology complicated by hyperferritinemia. The peptides contained in standardized HPH simultaneously help reduce chronic and excessive acute inflammation, normalize iron metabolism (including inhibiting the development of tissue hemosiderosis), and exhibit a regenerative effect on damaged organ parenchyma.
- 10 April 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 4
Hyperferritinemia in Multiorgan Disease. Diagnostic Criteria and Treatment Strategy Using Standardized Placental Extracts in Metabolic Fatty Liver Disease
Ferritin is an iron metabolism protein involved in the storage and protection of iron ions from uncontrolled oxidation. Serum ferritin levels are used as a biomarker to assess iron homeostasis. However, iron storage is not ferritin’s only biological function. Ferritin is an important biomarker of acute and chronic inflammation, and ferritin levels above 500-1000 ng/mL can indicate inflammatory processes of various origins. Therefore, in patients with existing inflammation, interpreting serum ferritin levels becomes more complex. Hyperferritinemia (ferritin levels of 500 ng/mL and above) accompanies not only iron overload but also liver disease, insulin resistance, cardiovascular and cerebrovascular pathology, COVID-19 (characterized by multiple organ dysfunction), and certain hematological disorders (macrophage activation syndrome, hemophagocytic lymphohistiocytosis) and corresponds to a more severe course of these pathologies. The results of an analysis of 34,266 publications on ferritin, conducted using mathematical methods of topological data analysis, suggest that ferritin (which is also a marker of acute and chronic inflammation) should only be used in combination with other biomarkers (transferrin, hemoglobin, hepcidin, etc.) to assess iron homeostasis. Diagnostic criteria that include serum ferritin levels should take into account the patient’s comorbidity. Depending on the pathology, ferritin levels can vary by four orders of magnitude: from 10-20 ng/ml for iron deficiency anemia to 900,000 ng/ml in individual cases of hemophagocytic lymphohistiocytosis. Ferritin thresholds in the range of 1000-6000 ng/ml are typical for iron overload diseases, macrophage activation syndrome, hemophagocytic lymphohistiocytosis, and coagulation disorders; ferritin thresholds in the range of 500-1000 ng/ml are typical for leukemia, blood transfusions, COVID-19, and other viral infections. At the same time, for bacterial infections, liver and kidney diseases, diabetes mellitus, vascular and neurodegenerative pathologies, threshold values of ferritin in the range of 300-500 ng/ml are of diagnostic interest, which approximately correspond to the established reference intervals for ferritin for adults. Therapeutic strategies for liver disease and other pathologies should consider hyperferritinemia as an indicator of a more severe course of the disease, including due to cytolysis of various tissues in multiorgan pathology. There are no established drugs for the treatment of diseases complicated by hyperferritinemia. Basic and clinical research shows that drugs based on standardized human placental hydrolysates (HPH) can be effectively used in multiorgan pathology complicated by hyperferritinemia. The peptides contained in standardized HPH simultaneously help reduce chronic and excessive acute inflammation, normalize iron metabolism (including inhibiting the development of tissue hemosiderosis), and exhibit a regenerative effect on damaged organ parenchyma.
- Open Access
- 29 March 2024
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 5 (1) , 7-14
Ventricular arrhythmias in patients with chronic heart failure and central sleep apnea with Cheyne-Stokes respiration
The review is devoted to the influence of central sleep apnea and Cheyne-Stokes breathing on the prognosis of patients with chronic heart failure. The connection between sleep breathing disorders and an increased risk of ventricular arrhythmias and the mechanisms of these interactions are discussed, and options for approaches to therapy are considered.
- 29 March 2024
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 5 (1) , 7-14
Open AccessVentricular arrhythmias in patients with chronic heart failure and central sleep apnea with Cheyne-Stokes respiration
The review is devoted to the influence of central sleep apnea and Cheyne-Stokes breathing on the prognosis of patients with chronic heart failure. The connection between sleep breathing disorders and an increased risk of ventricular arrhythmias and the mechanisms of these interactions are discussed, and options for approaches to therapy are considered.
- Open Access
- 12 March 2024
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 5 (1) , 68-77
Association of iron metabolism with erythrocyte parameters, myeloid and lymphoid cells in patients with sleep disorders
Objective: to identify the relationship between the main indicators of iron metabolism and erythrocyte parameters, myeloid and lymphoid cells in patients with sleep disorders in patients with sleep disorders (obstructive sleep apnea (OSA), chronic insomnia (CI), restless legs syndrome (RLS)). Materials and methods: 118 patients, 60 men (50.8%) and 58 women (49.2%), Me age — 47 years (Q1–Q3: 35–61), Me BMI — 25.81 kg/m2 (Q1–Q3: 22.72–29.40) with obstructive sleep apnea (OSA), chronic insomnia, restless legs syndrome in their various combinations. All patients underwent a polysomnographic study, blood cell count, biochemical parameters of iron metabolism were assessed. Results: when assessing the relationship between “Ferritin” and “Hemoglobin”, “Hematocrit (%)”, “Erythrocytes”, “Lymphocytes, abs.”, a moderate direct relationship was established (pConclusions: in patients with sleep disorders, a statistically significant relationship was revealed between the main parameters of iron metabolism and indicators of “red” blood, the content of neutrophils and lymphocytes. It was shown for the first time that in patients with sleep disorders, changes in the content of neutrophils and lymphocytes may be associated not only with changes in sleep itself, but also with the state of iron metabolism. The complex relationships of iron metabolism, the function of erythrocytes, neutrophils and lymphocytes in patients with sleep disorders can affect the development of both infectious and non-infectious diseases through the mechanisms of maintaining chronic inflammation, hypoferemia, ferroptosis, netosis and other mechanisms.
- 12 March 2024
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 5 (1) , 68-77
Open AccessAssociation of iron metabolism with erythrocyte parameters, myeloid and lymphoid cells in patients with sleep disorders
Objective: to identify the relationship between the main indicators of iron metabolism and erythrocyte parameters, myeloid and lymphoid cells in patients with sleep disorders in patients with sleep disorders (obstructive sleep apnea (OSA), chronic insomnia (CI), restless legs syndrome (RLS)). Materials and methods: 118 patients, 60 men (50.8%) and 58 women (49.2%), Me age — 47 years (Q1–Q3: 35–61), Me BMI — 25.81 kg/m2 (Q1–Q3: 22.72–29.40) with obstructive sleep apnea (OSA), chronic insomnia, restless legs syndrome in their various combinations. All patients underwent a polysomnographic study, blood cell count, biochemical parameters of iron metabolism were assessed. Results: when assessing the relationship between “Ferritin” and “Hemoglobin”, “Hematocrit (%)”, “Erythrocytes”, “Lymphocytes, abs.”, a moderate direct relationship was established (pConclusions: in patients with sleep disorders, a statistically significant relationship was revealed between the main parameters of iron metabolism and indicators of “red” blood, the content of neutrophils and lymphocytes. It was shown for the first time that in patients with sleep disorders, changes in the content of neutrophils and lymphocytes may be associated not only with changes in sleep itself, but also with the state of iron metabolism. The complex relationships of iron metabolism, the function of erythrocytes, neutrophils and lymphocytes in patients with sleep disorders can affect the development of both infectious and non-infectious diseases through the mechanisms of maintaining chronic inflammation, hypoferemia, ferroptosis, netosis and other mechanisms.
- Open Access
- 26 December 2023
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS) in Nauchno-prakticheskii zhurnal «Patogenez»
- Vol. 21 (4) , 53-60
Use of oxidative stress parameters as a potential biomarker in the blood of patients with an increased risk of developing Parkinson’s disease at the prodromal stage
Болезнь Паркинсона (БП) является хроническим и прогрессирующим нейродегенеративным заболеванием, развивающимся в результате повреждения и гибели дофаминергических нейронов в чёрной субстанции. Клинический диагноз БП определяют спустя много лет от начала развития заболевания, когда значительная часть пула нигростриатных дофаминергичеких нейронов погибает. Возможно, с этим связана относительная низкая эффективность применяемой заместительной терапии в виде леводопасодержащих препаратов. В связи с этим главным приоритетом исследователей является поиск диагностических средств выявления БП на доклинической (продромальной) стадии. Учитывая, что одним из главных механизмов повреждения и смерти нигральных дофаминергических является окислительный стресс, целью данной работы было изучение изменений показателей окислительного стресса в крови пациентов группы риска развития БП, которые могли бы считаться потенциальными диагностическими биомаркёрами на продромальной стадии заболевания. Материалы и методы. В исследовании приняли участие 26 пациентов группы риска развития БП и 20 лиц соответсвующего возраста в качестве группы контроля. Главным критерием включения пациентов в группу риска развития БП явилось наличие расстройств поведения во время сна, нарушение обонятельной функции, вегетативная дисфункция кишечника (запор), а также неврологические и психические расстройства. Общий окислительный статус, общий антиоксидантный статус в плазме крови пациентов группы риска развития БП и группы сравнения определяли спектрофотометрическим методом. Результаты. Показано, что в крови пациентов группы общего риска повышен индекс окислительного стресса и уровень общего окислительного статуса, а также снижен уровень антиокислительного стресса. Заключение. Предполагается, что параметры окислительного стресса могут быть использованы в качестве диагностических биомаркёров на продромальной стадии БП. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disease that results from damage and death of dopaminergic neurons in the substantia nigra. The clinical diagnosis of PD is determined many years after the onset of the disease, when a significant part of the pool of nigrostriatal dopaminergic neurons die. This may be due to the relative low effectiveness of the replacement therapy used in the form of levodopa-containing drugs. In this regard, the main priority of researchers is to search for diagnostic tools for detecting PD at the preclinical (prodromal) stage. One of the main mechanisms of damage and death of nigral dopaminergic neurons is oxidative stress (OS). The purpose of this work wasto study changes in the oxidative stress index, as an integrative parameter of oxidative stress in the blood of patients at risk for developing PD, which could be considered potential diagnostic biomarkers at the prodromal stage of the disease. Methods: The study involved 26 patients at risk of developing PD and 20 age-matched individuals as a control group. The main criterion for including patients at risk for developing PD was disturbances in sleep behavior, olfactory function, autonomic intestinal dysfunction (constipation), as well as neurological and mental disorders. Total oxidative status, total antioxidant status in the blood plasma of patients at risk for developing PD and the comparison group were determined by the spectrophotometric method. Results. It has been shown that in the blood of patients at risk, the index of oxidative stress and the level of total oxidative status are increased, and the level of antioxidant status is reduced. Conclusion. It is assumed that oxidative stress parameters may be candidates for the role of diagnostic biomarkers at the prodromal stage of PD.
- 26 December 2023
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS) in Nauchno-prakticheskii zhurnal «Patogenez»
- Vol. 21 (4) , 53-60
Open AccessUse of oxidative stress parameters as a potential biomarker in the blood of patients with an increased risk of developing Parkinson’s disease at the prodromal stage
Болезнь Паркинсона (БП) является хроническим и прогрессирующим нейродегенеративным заболеванием, развивающимся в результате повреждения и гибели дофаминергических нейронов в чёрной субстанции. Клинический диагноз БП определяют спустя много лет от начала развития заболевания, когда значительная часть пула нигростриатных дофаминергичеких нейронов погибает. Возможно, с этим связана относительная низкая эффективность применяемой заместительной терапии в виде леводопасодержащих препаратов. В связи с этим главным приоритетом исследователей является поиск диагностических средств выявления БП на доклинической (продромальной) стадии. Учитывая, что одним из главных механизмов повреждения и смерти нигральных дофаминергических является окислительный стресс, целью данной работы было изучение изменений показателей окислительного стресса в крови пациентов группы риска развития БП, которые могли бы считаться потенциальными диагностическими биомаркёрами на продромальной стадии заболевания. Материалы и методы. В исследовании приняли участие 26 пациентов группы риска развития БП и 20 лиц соответсвующего возраста в качестве группы контроля. Главным критерием включения пациентов в группу риска развития БП явилось наличие расстройств поведения во время сна, нарушение обонятельной функции, вегетативная дисфункция кишечника (запор), а также неврологические и психические расстройства. Общий окислительный статус, общий антиоксидантный статус в плазме крови пациентов группы риска развития БП и группы сравнения определяли спектрофотометрическим методом. Результаты. Показано, что в крови пациентов группы общего риска повышен индекс окислительного стресса и уровень общего окислительного статуса, а также снижен уровень антиокислительного стресса. Заключение. Предполагается, что параметры окислительного стресса могут быть использованы в качестве диагностических биомаркёров на продромальной стадии БП. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disease that results from damage and death of dopaminergic neurons in the substantia nigra. The clinical diagnosis of PD is determined many years after the onset of the disease, when a significant part of the pool of nigrostriatal dopaminergic neurons die. This may be due to the relative low effectiveness of the replacement therapy used in the form of levodopa-containing drugs. In this regard, the main priority of researchers is to search for diagnostic tools for detecting PD at the preclinical (prodromal) stage. One of the main mechanisms of damage and death of nigral dopaminergic neurons is oxidative stress (OS). The purpose of this work wasto study changes in the oxidative stress index, as an integrative parameter of oxidative stress in the blood of patients at risk for developing PD, which could be considered potential diagnostic biomarkers at the prodromal stage of the disease. Methods: The study involved 26 patients at risk of developing PD and 20 age-matched individuals as a control group. The main criterion for including patients at risk for developing PD was disturbances in sleep behavior, olfactory function, autonomic intestinal dysfunction (constipation), as well as neurological and mental disorders. Total oxidative status, total antioxidant status in the blood plasma of patients at risk for developing PD and the comparison group were determined by the spectrophotometric method. Results. It has been shown that in the blood of patients at risk, the index of oxidative stress and the level of total oxidative status are increased, and the level of antioxidant status is reduced. Conclusion. It is assumed that oxidative stress parameters may be candidates for the role of diagnostic biomarkers at the prodromal stage of PD.
- Open Access
- 8 December 2023
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 4 (4) , 41-50
The degree of ischemia-reperfusion as a possible risk factor for the development of atrial fibrillation in patients with obstructive sleep apnea syndrome
Objective: the purpose of this study was to identify possible factors for the occurrence of atrial fibrillation (AF) in patients with obstructive sleep apnea syndrome (OSA). Materials and methods: the retrospective study included 50 patients (38 men and 12 women, average age 53 (13) years) admitted to Sleep Medicine Center of University clinic of Lomonosov State University with complaints of snoring and stop of breathig during sleep and who underwent a polysomnographic study. The study included only patients with moderate and severe OSA. For all patients included in the study, the presence of comorbidities was assessed: arterial hypertension (HTN), type 2 diabetes mellitus (DM), coronary heart disease (CHD) and restless legs syndrome (RLS). Results: 11 patients had a history of atrial fibrillation and/or during polysomnography. When assessing heart rhythm during a polysomnographic study, 5 patients (10%) had AF, of which 1 patient had not previously reported the presence of arrhythmia. A predictive model was developed to estimate the probability of AF (atrium fibrillation) conditioning on age, average desaturation, % using binary logistic regression. The resulting regression model is statistically significant (p < 0.001). Based on the value of Nagelkerke R², the model explains 50.6% of the observed AF variance. 1 increase of age is associated with 1.211 times increase in AF odds. 1 increase of average desaturation, % is associated with 1.448 times increase in AF odds. Conclusions: it was shown for the first time that, along with such a well-known risk factor for AF as age, parameters of respiratory disorders during sleep, namely, average desaturation, can play a role in the development of AF through the mechanisms of myocardial ischemia-reperfusion. Average desaturation, reflecting the degree of ischemia-reperfusion, may become a risk factor for the development of AF.
- 8 December 2023
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 4 (4) , 41-50
Open AccessThe degree of ischemia-reperfusion as a possible risk factor for the development of atrial fibrillation in patients with obstructive sleep apnea syndrome
Objective: the purpose of this study was to identify possible factors for the occurrence of atrial fibrillation (AF) in patients with obstructive sleep apnea syndrome (OSA). Materials and methods: the retrospective study included 50 patients (38 men and 12 women, average age 53 (13) years) admitted to Sleep Medicine Center of University clinic of Lomonosov State University with complaints of snoring and stop of breathig during sleep and who underwent a polysomnographic study. The study included only patients with moderate and severe OSA. For all patients included in the study, the presence of comorbidities was assessed: arterial hypertension (HTN), type 2 diabetes mellitus (DM), coronary heart disease (CHD) and restless legs syndrome (RLS). Results: 11 patients had a history of atrial fibrillation and/or during polysomnography. When assessing heart rhythm during a polysomnographic study, 5 patients (10%) had AF, of which 1 patient had not previously reported the presence of arrhythmia. A predictive model was developed to estimate the probability of AF (atrium fibrillation) conditioning on age, average desaturation, % using binary logistic regression. The resulting regression model is statistically significant (p < 0.001). Based on the value of Nagelkerke R², the model explains 50.6% of the observed AF variance. 1 increase of age is associated with 1.211 times increase in AF odds. 1 increase of average desaturation, % is associated with 1.448 times increase in AF odds. Conclusions: it was shown for the first time that, along with such a well-known risk factor for AF as age, parameters of respiratory disorders during sleep, namely, average desaturation, can play a role in the development of AF through the mechanisms of myocardial ischemia-reperfusion. Average desaturation, reflecting the degree of ischemia-reperfusion, may become a risk factor for the development of AF.
- Open Access
- 17 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1842
Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
Parkinson’s disease (PD) is diagnosed many years after its onset, under a significant degradation of the nigrostriatal dopaminergic system, responsible for the regulation of motor function. This explains the low effectiveness of the treatment of patients. Therefore, one of the highest priorities in neurology is the development of the early (preclinical) diagnosis of PD. The aim of this study was to search for changes in the blood of patients at risk of developing PD, which are considered potential diagnostic biomarkers. Out of 1835 patients, 26 patients were included in the risk group and 20 patients in the control group. The primary criteria for inclusion in a risk group were the impairment of sleep behavior disorder and sense of smell, and the secondary criteria were neurological and mental disorders. In patients at risk and in controls, the composition of plasma and the expression of genes of interest in lymphocytes were assessed by 27 indicators. The main changes that we found in plasma include a decrease in the concentrations of l-3,4-dihydroxyphenylalanine (L-DOPA) and urates, as well as the expressions of some types of microRNA, and an increase in the total oxidative status. In turn, in the lymphocytes of patients at risk, an increase in the expression of the DA D3 receptor gene and the lymphocyte activation gene 3 (LAG3), as well as a decrease in the expression of the Protein deglycase DJ-1 gene (PARK7), were observed. The blood changes we found in patients at risk are considered candidates for diagnostic biomarkers at the prodromal stage of PD.
- 17 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1842
Open AccessSearching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
Parkinson’s disease (PD) is diagnosed many years after its onset, under a significant degradation of the nigrostriatal dopaminergic system, responsible for the regulation of motor function. This explains the low effectiveness of the treatment of patients. Therefore, one of the highest priorities in neurology is the development of the early (preclinical) diagnosis of PD. The aim of this study was to search for changes in the blood of patients at risk of developing PD, which are considered potential diagnostic biomarkers. Out of 1835 patients, 26 patients were included in the risk group and 20 patients in the control group. The primary criteria for inclusion in a risk group were the impairment of sleep behavior disorder and sense of smell, and the secondary criteria were neurological and mental disorders. In patients at risk and in controls, the composition of plasma and the expression of genes of interest in lymphocytes were assessed by 27 indicators. The main changes that we found in plasma include a decrease in the concentrations of l-3,4-dihydroxyphenylalanine (L-DOPA) and urates, as well as the expressions of some types of microRNA, and an increase in the total oxidative status. In turn, in the lymphocytes of patients at risk, an increase in the expression of the DA D3 receptor gene and the lymphocyte activation gene 3 (LAG3), as well as a decrease in the expression of the Protein deglycase DJ-1 gene (PARK7), were observed. The blood changes we found in patients at risk are considered candidates for diagnostic biomarkers at the prodromal stage of PD.
- Open Access
- 13 December 2022
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 12 (4) , 20-28
Anemia in patients with inflammatory bowel disease as a risk factor for restless legs syndrome. Literature review
Restless legs syndrome (RLS) is a neurological, sensorimotor disorder. It is characterized by the uncomfortable and unpleasant sensations in the legs which begin or worsen during periods of rest, primarily in the evening or night, and are relieved by movement. Central iron deficiency plays a vital role in the pathogenesis of RLS. There is evidence that chronic inflammation is an additional risk factor for RLS. Anemia is the most common complication and extraintestinal manifestation of inflammatory bowel disease, therefore the prevalence of RLS in these patients is a problem of great interest. In addition, inflammatory bowel disease patients’ sleep disturbances directly influence the disease’s clinical course and can be the preclinical marker of exacerbation. It is essential for clinicians to be aware of RLS as a possible reason for sleep disturbance and as a factor that negatively affects the quality of life in inflammatory bowel disease patients.
- 13 December 2022
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 12 (4) , 20-28
Open AccessAnemia in patients with inflammatory bowel disease as a risk factor for restless legs syndrome. Literature review
Restless legs syndrome (RLS) is a neurological, sensorimotor disorder. It is characterized by the uncomfortable and unpleasant sensations in the legs which begin or worsen during periods of rest, primarily in the evening or night, and are relieved by movement. Central iron deficiency plays a vital role in the pathogenesis of RLS. There is evidence that chronic inflammation is an additional risk factor for RLS. Anemia is the most common complication and extraintestinal manifestation of inflammatory bowel disease, therefore the prevalence of RLS in these patients is a problem of great interest. In addition, inflammatory bowel disease patients’ sleep disturbances directly influence the disease’s clinical course and can be the preclinical marker of exacerbation. It is essential for clinicians to be aware of RLS as a possible reason for sleep disturbance and as a factor that negatively affects the quality of life in inflammatory bowel disease patients.
- Open Access
- 29 December 2021
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 27 (5) , 553-561
Age and sex differences in sleep disorders as risk factors and markers of hypertension in young people with normal body weight
Objective. To assess age and sex differences in sleep disorders as risk factors and markers of hypertension (HTN) in 18–39-year old people with normal body weight. Design and methods. We performed a cross-sectional study based on the internet survey of 18–39-year-old people with body mass index of 18–25 kg/m2 (n = 2094). The unvalidated questionnaire included 42 questions about various types of sleep disorders and sleep-associated symptoms (0 — never, 1 — rarely, 2 — from time to time, 3 — quite often, 4 — almost all the time). Results. The probability of detecting HTN in young men with normal body weight is higher than in women with similar characteristics (p < 0,001). In women, the probability of detecting HTN decreases, starting with the youngest category (18–24 years old), reaching a minimum in the age group 30–34 years old and then starts to increase. By the age of 40, the indicators for men and women become similar. Based on a multivariate analysis, the risk of HTN in young people with normal body weight is associated with both gender and age (p = 0,022). The contribution of gender to age-related changes in sleep complaints was found for snoring (p < 0,001), sleep apnea (p < 0,001), early awakenings (p = 0,002). The contribution of gender was also noted for various symptoms — daytime sleepiness, some symptoms of restless legs syndrome (RLS), anxiety, depression, leg cramps (p < 0,001) and nocturnal heartburn (p < 0,001). The contribution of age was noted for snoring (p < 0,001), sleep apnea (p < 0,001), early awakenings (p < 0,001) and for a variety of symptoms — daytime sleepiness, some symptoms of RLS, anxiety, nocturnal cough, and nocturnal choking. Conclusions. Our data can be considered when developing measures for HTN prevention, can be recommended for clinical use, as well as in subsequent clinical studies using validated questionnaires.
- 29 December 2021
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 27 (5) , 553-561
Open AccessAge and sex differences in sleep disorders as risk factors and markers of hypertension in young people with normal body weight
Objective. To assess age and sex differences in sleep disorders as risk factors and markers of hypertension (HTN) in 18–39-year old people with normal body weight. Design and methods. We performed a cross-sectional study based on the internet survey of 18–39-year-old people with body mass index of 18–25 kg/m2 (n = 2094). The unvalidated questionnaire included 42 questions about various types of sleep disorders and sleep-associated symptoms (0 — never, 1 — rarely, 2 — from time to time, 3 — quite often, 4 — almost all the time). Results. The probability of detecting HTN in young men with normal body weight is higher than in women with similar characteristics (p < 0,001). In women, the probability of detecting HTN decreases, starting with the youngest category (18–24 years old), reaching a minimum in the age group 30–34 years old and then starts to increase. By the age of 40, the indicators for men and women become similar. Based on a multivariate analysis, the risk of HTN in young people with normal body weight is associated with both gender and age (p = 0,022). The contribution of gender to age-related changes in sleep complaints was found for snoring (p < 0,001), sleep apnea (p < 0,001), early awakenings (p = 0,002). The contribution of gender was also noted for various symptoms — daytime sleepiness, some symptoms of restless legs syndrome (RLS), anxiety, depression, leg cramps (p < 0,001) and nocturnal heartburn (p < 0,001). The contribution of age was noted for snoring (p < 0,001), sleep apnea (p < 0,001), early awakenings (p < 0,001) and for a variety of symptoms — daytime sleepiness, some symptoms of RLS, anxiety, nocturnal cough, and nocturnal choking. Conclusions. Our data can be considered when developing measures for HTN prevention, can be recommended for clinical use, as well as in subsequent clinical studies using validated questionnaires.
- Open Access
- 28 October 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (56) , 35351-35360
New facets of nanozyme activity of ceria: lipo- and phospholipoperoxidase-like behaviour of CeO 2 nanoparticles
CeO 2 nanoparticles were shown to possess two novel types of enzyme-like activity, namely lipoperoxidase and phospholipoperoxidase activity.
- 28 October 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (56) , 35351-35360
Open AccessNew facets of nanozyme activity of ceria: lipo- and phospholipoperoxidase-like behaviour of CeO 2 nanoparticles
CeO 2 nanoparticles were shown to possess two novel types of enzyme-like activity, namely lipoperoxidase and phospholipoperoxidase activity.